Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics Signs Coverage Agreement With Blue Cross Blue Shield of Minnesota

NEW YORK (GenomeWeb) – Cancer Genetics announced today that it has signed an in-network provider agreement with Blue Cross Blue Shield (BCBS) of Minnesota to provide access to its cancer diagnostics and genomic testing services to the healthcare network's 2.6 million members.

BCBS Minnesota is the largest health plan in the state, the company said in a statement.

The company signed several similar coverage agreements in 2015 with various insurance providers, including BCBS Illinois in September to cover 7.3 million people, and with with BCBS North Carolina, BCBS Nebraska, and WellMark in November to cover a total of 6.7 million people. CGI said it now has contracts with 29 payers covering 180 million lives across commercial Medicare advantage and Medicaid plans.

"We are looking forward to offering our comprehensive portfolio of oncology diagnostic tests to help Minnesotans have the most effective and high-quality personalized cancer care available," Randy Goodman, Cancer Genetics' director of reimbursement and clinical revenue cycle management, said in a statement."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more